Aries Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.95M | Sell |
11,730
-500
| -4% | -$108K | 0.58% | 37 |
|
|
2026
Q1 | $2.66M | Sell |
12,230
-500
| -4% | -$111K | 0.58% | 42 |
|
|
2025
Q4 | $2.91M | Sell |
12,730
-27
| -0.2% | -$6.15K | 0.64% | 37 |
|
|
2025
Q3 | $2.95M | Sell |
12,757
-410
| -3% | -$83.5K | 0.7% | 36 |
|
|
2025
Q2 | $2.44M | Sell |
13,167
-150
| -1% | -$27.9K | 0.64% | 39 |
|
|
2025
Q1 | $2.79M | Hold |
13,317
| – | – | 0.76% | 35 |
|
|
2024
Q4 | $2.37M | Sell |
13,317
-215
| -2% | -$39.5K | 0.65% | 40 |
|
|
2024
Q3 | $2.67M | Buy |
13,532
+468
| +4% | +$87.3K | 0.73% | 36 |
|
|
2024
Q2 | $2.24M | Buy |
13,064
+16
| +0.1% | +$2.65K | 0.71% | 35 |
|
|
2024
Q1 | $2.38M | Sell |
13,048
-30
| -0.2% | -$5.17K | 0.77% | 36 |
|
|
2023
Q4 | $2.03M | Sell |
13,078
-182
| -1% | -$26.5K | 0.72% | 35 |
|
|
2023
Q3 | $1.95M | Buy |
13,260
+535
| +4% | +$78.5K | 0.76% | 36 |
|
|
2023
Q2 | $1.71M | Hold |
12,725
| – | – | 0.66% | 41 |
|
|
2023
Q1 | $2.03M | Buy |
12,725
+175
| +1% | +$26.8K | 0.83% | 31 |
|
|
2022
Q4 | $2.03M | Buy |
12,550
+150
| +1% | +$23K | 0.87% | 32 |
|
|
2022
Q3 | $1.81M | Buy |
12,400
+152
| +1% | +$21.8K | 0.8% | 38 |
|
|
2022
Q2 | $1.88M | Buy |
+12,248
| New | +$1.87M | 0.85% | 32 |
|
|
2022
Q1 | – | Sell |
-12,098
| Closed | -$1.64M | – | 74 |
|
|
2021
Q4 | $1.64M | Buy |
12,098
+160
| +1% | +$18.9K | 0.62% | 40 |
|
|
2021
Q3 | $1.29M | Buy |
11,938
+35
| +0.3% | +$4K | 0.54% | 50 |
|
|
2021
Q2 | $1.34M | Buy |
11,903
+135
| +1% | +$15.2K | 0.57% | 47 |
|
|
2021
Q1 | $1.25M | Buy |
11,768
+2,048
| +21% | +$219K | 0.56% | 47 |
|
|
2020
Q4 | $1.04M | Hold |
9,720
| – | – | 0.52% | 52 |
|
|
2020
Q3 | $851K | Hold |
9,720
| – | – | 0.48% | 50 |
|
|
2020
Q2 | $954K | Buy |
9,720
+300
| +3% | +$26.4K | 0.58% | 48 |
|
|
2020
Q1 | $708K | Sell |
9,420
-1,000
| -10% | -$85.2K | 0.54% | 52 |
|
|
2019
Q4 | $932K | Hold |
10,420
| – | – | 0.57% | 50 |
|
|
2019
Q3 | $767K | Sell |
10,420
-1,400
| -12% | -$96K | 0.51% | 54 |
|
|
2019
Q2 | $863K | Hold |
11,820
| – | – | 0.6% | 47 |
|
|
2019
Q1 | $953K | Sell |
11,820
-600
| -5% | -$49.1K | 0.71% | 44 |
|
|
2018
Q4 | $1.15M | Hold |
12,420
| – | – | 1.21% | 29 |
|
|
2018
Q3 | $1.18M | Hold |
12,420
| – | – | 1.06% | 29 |
|
|
2018
Q2 | $1.15M | Sell |
12,420
-950
| -7% | -$92.8K | 1.06% | 29 |
|
|
2018
Q1 | $1.25M | Sell |
13,370
-202
| -1% | -$22.2K | 1.21% | 26 |
|
|
2017
Q4 | $1.42M | Buy |
+13,572
| New | +$1.28M | 1.31% | 24 |
|
Other funds holding ABBV
Aries Wealth Management's ABBV Position: Q2 2026 in Review
Aries Wealth Management reduced its AbbVie (ABBV) stake by 4.1% in Q2 2026, selling an estimated $108K and leaving 11,730 shares worth $2.95M. The position accounts for 0.58% of the portfolio, ranked #37.
Aries Wealth Management first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.95M in Q3 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Aries Wealth Management held 11,730 shares of AbbVie worth $2.95M as of Q2 2026.
- Aries Wealth Management sold 500 AbbVie shares in Q2 2026, an estimated $108K.
- AbbVie made up 0.58% of Aries Wealth Management's portfolio in Q2 2026, its #37 holding.
- Aries Wealth Management first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
- Aries Wealth Management's AbbVie position peaked at $2.95M in Q3 2025.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Aries Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.